Sopharma AD (BUL:3JR) signed a contract to acquire remaining 7.4% stake in Momina Krepost AD (BUL:5MR) for BGN 0.22 million on September 17, 2015. Under the terms of the contract, each shareholder of Momina Krepost will receive 0.655675 Sopharma shares. Sopharma's capital will not be increased through the issue of new shares.

All documents related to the contract are subject to review by the financial supervision commission. After the completion of the transaction Sopharma AD will become the legal successor of Momina Krepost AD. ELANA Trading acted as the financial advisor to Sopharma AD (BUL:3JR).